Literature DB >> 11412133

Immunological capabilities of skeletal muscle cells.

K Nagaraju1.   

Abstract

Muscle is the target of immunological injury in several muscle diseases. It is important therefore to understand the immunological capabilities of muscle cells themselves. Although it is conventional to discuss the effects of the immune system on other cells, tissues or organs, the system's boundaries cannot be sharply drawn, and in an increasing number of ways, the immunological capabilities of non-immune tissues are recognized as determining the course of immune-inflammatory processes. Muscle cells have an inherent ability to express and respond to a variety of immunologically relevant surface molecules, cytokines, and chemokines under inflammatory conditions. The ability of muscle cells to process and present antigens to the immune cells is currently debated; thus, this review is aimed at examining the immunological capabilities of skeletal muscle cells in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11412133     DOI: 10.1046/j.1365-201x.2001.00823.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  13 in total

Review 1.  The potential of adeno-associated viral vectors for gene delivery to muscle tissue.

Authors:  Dan Wang; Li Zhong; M Abu Nahid; Guangping Gao
Journal:  Expert Opin Drug Deliv       Date:  2014-01-03       Impact factor: 6.648

2.  A robust in vitro screening assay to identify NF-kappaB inhibitors for inflammatory muscle diseases.

Authors:  Andreas R Baudy; Nandita Saxena; Heather Gordish; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  Int Immunopharmacol       Date:  2009-07-21       Impact factor: 4.932

3.  Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2.

Authors:  Qi Liu; Fuwu Wang; Guan Wang; Qunli Zhao; Juan Min; Shuai Wang; Hua Cong; Ying Li; Shenyi He; Huaiyu Zhou
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

Review 4.  Vaccines for multiple sclerosis: progress to date.

Authors:  Jorge Correale; Mauricio Farez; Wendy Gilmore
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Cell-mediated response at the muscle phase of Trichinella pseudospiralis and Trichinella spiralis infections.

Authors:  K M Lee; R C Ko
Journal:  Parasitol Res       Date:  2006-02-18       Impact factor: 2.289

6.  Disease-associated increased HIF-1, alphavbeta3 integrin, and Flt-1 do not suffice to compensate the damage-inducing loss of blood vessels in inflammatory myopathies.

Authors:  Yrjö T Konttinen; Zygmunt Mackiewicz; Danute Povilenaite; Antti Sukura; Mika Hukkanen; Ismo Virtanen
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

Review 7.  The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

8.  In Vivo Molecular Responses of Fast and Slow Muscle Fibers to Lipopolysaccharide in a Teleost Fish, the Rainbow Trout (Oncorhynchus mykiss).

Authors:  Leonardo J Magnoni; Nerea Roher; Diego Crespo; Aleksei Krasnov; Josep V Planas
Journal:  Biology (Basel)       Date:  2015-02-04

9.  The IRE1α Arm of UPR Regulates Muscle Cells Immune Characters by Restraining p38 MAPK Activation.

Authors:  RuiCai Gu; Tao Huang; JiangWei Xiao; ZhaoHong Liao; JunHua Li; HaiQiang Lan; Jun Ouyang; JiJie Hu; Hua Liao
Journal:  Front Physiol       Date:  2019-09-19       Impact factor: 4.566

10.  Profiling of remote skeletal muscle gene changes resulting from stimulation of atopic dermatitis disease in NC/Nga mouse model.

Authors:  Donghee Lee; Yelim Seo; Young-Won Kim; Seongtae Kim; Jeongyoon Choi; Sung-Hee Moon; Hyemi Bae; Hui-Sok Kim; Hangyeol Kim; Jae-Hyun Kim; Tae-Young Kim; Eunho Kim; Suemin Yim; Inja Lim; Hyoweon Bang; Jung-Ha Kim; Jae-Hong Ko
Journal:  Korean J Physiol Pharmacol       Date:  2019-08-26       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.